July 18: Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review
Cannabis Law Report
JULY 21, 2022
Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. A spokesperson told CBC in an email that the study was put on hold “due to concerns for participant safety.”
Let's personalize your content